A New Form of Ectodermal Dysplasia Caused by Mutations in TSPEAR

    A. Peled, Ofer Sarig, Liat Samuelov, Marta Bertolini, Limor Ziv, Daphna Weissglas‐Volkov, Marina Eskin‐Schwartz, Christopher A. Adase, N. Malchin, Ron Bochner, Gilad Fainberg, Koji Sugawara, Avital Baniel, Daisuke Tsuruta, C. Luxemburg, Noam Adir, Ivan Goldberg, Richard L. Gallo, Noam Shomron, Ralf Paus, Eli Sprecher
    TLDR Mutations in the TSPEAR gene cause a new form of ectodermal dysplasia affecting hair and tooth development.
    The study identified mutations in the TSPEAR gene in 3 families with a new form of ectodermal dysplasia (ED) characterized by facial dysmorphism, scalp hypotrichosis, body hypertrichosis, and hypodontia. Whole exome sequencing revealed 2 frameshift and 2 missense mutations. The research suggested that abnormal NOTCH signaling was involved, as TSPEAR down-regulation in keratinocytes led to decreased NOTCH1 mRNA and protein levels. This down-regulation also affected genes involved in hair and tooth development, such as TP63 and TGFBR2. In vivo experiments using siRNA to knock down TSPEAR in human and mouse hair follicles showed inhibited hair growth and altered hair keratin expression. The findings indicated that TSPEAR played a critical role in hair and tooth morphogenesis.
    Discuss this study in the Community →

    Related Community Posts Join

    3 / 3 results

      community Hair loss research is a money grab

      in Chat  217 upvotes 2 weeks ago
      Hair loss is linked to DHT, with treatments like finasteride and minoxidil being common but not definitive. Economic interests influence research, and there is potential for new treatments like PP405 and RU58841.

      community OFFICIAL Multi-Center Verteporfin Trial Recruitment

      in Research/Science  251 upvotes 5 months ago
      Recruitment for a verteporfin trial and a separate hair cloning trial using verteporfin and other methods is underway, with locations in Jordan, NYC, Beverly Hills, and Memphis. Dr. Bloxham is conducting the hair cloning trial, and interested participants are encouraged to contact him directly.

      community Verteporfin and Microneedling

      in Treatments 1 year ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.

    Similar Research

    5 / 1000+ results